Biomaterial Database

Haemolytic uraemic syndrome during cyclosporin therapy for Behcet's disease. 1997

A Chatterjee, and R J D'Souza

UI	MeSH Term	Description	Entries
D007166	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.	Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D005260	Female		Females
D006463	Hemolytic-Uremic Syndrome	A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.	Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D001528	Behcet Syndrome	Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.	Behcet Disease,Behcet's Disease,Behcet's Syndrome,Triple-Symptom Complex,Adamantiades-Behcet Disease,Behcet Triple Symptom Complex,Behçet Disease,Old Silk Route Disease,Triple Symptom Complex,Adamantiades Behcet Disease,Adamantiades-Behcet Diseases,Behçet Diseases,Symptom Complex, Triple,Triple Symptom Complices
D016572	Cyclosporine	A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).	Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

A Chatterjee, and R J D'Souza

Haemolytic uraemic syndrome during FK506 therapy.

July 1992, Lancet (London, England),

A Chatterjee, and R J D'Souza

Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient.

December 1984, Lancet (London, England),

A Chatterjee, and R J D'Souza

Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.

January 1989, Lancet (London, England),

A Chatterjee, and R J D'Souza

Haemolytic uraemic syndrome during shigellosis.

July 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene,

A Chatterjee, and R J D'Souza

Cyclosporin-induced haemolytic-uraemic syndrome presenting as primary graft dysfunction.

November 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

A Chatterjee, and R J D'Souza

Haemolytic-uraemic syndrome and heparin therapy.

September 1969, Lancet (London, England),

A Chatterjee, and R J D'Souza

Haemolytic-uraemic syndrome and heparin therapy.

January 1970, Lancet (London, England),

A Chatterjee, and R J D'Souza

Thrombolytic therapy in haemolytic--uraemic syndrome.

July 1974, British medical journal,

A Chatterjee, and R J D'Souza

Haemolytic uraemic syndrome.

February 2017, Journal of internal medicine,